Related Experiment Video
Updated: Oct 13, 2025
06:29
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
2.5K
[Bilateral central serous chorioretinopathy post-COVID-19].
A Mahjoub1, A Dlensi1, A Romdhane1
1Service d'ophtalmologie, CHU Farhat Hached, Sousse, Tunisie.
Journal Francais D'Ophtalmologie
|November 10, 2021
Summary
A rare case of central serous chorioretinopathy occurred in a woman after COVID-19 infection. Prompt ophthalmologic examination is crucial for early detection of potential ocular complications.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Retinal Diseases
Background:
- Coronavirus disease (COVID-19) is known to cause various ocular manifestations.
- Central serous chorioretinopathy (CSC) is a condition affecting the retina, potentially leading to vision impairment.
Observation:
- A 38-year-old woman experienced bilateral blurred vision one month post-COVID-19 infection.
- She had a history of fever, cough, shortness of breath, and a positive COVID-PCR test.
- Ocular examination revealed bilateral serous retinal detachments.
Findings:
- The patient's corrected visual acuity was 3/10 in both eyes.
- Optical coherence tomography and fluorescein angiography confirmed bilateral serous retinal detachments.
- Visual acuity improved and retinal detachments regressed over time.
Implications:
- COVID-19 infection may be associated with the development of central serous chorioretinopathy.
- Corticosteroid treatment, often used for COVID-19, can be a contributing factor to CSC.
- Regular ophthalmologic examinations are vital for identifying and managing ocular complications post-COVID-19.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
886
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
886
01:27Open Angle Glaucoma: Treatment
748
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
748
01:25Glaucoma: Overview
961
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
961